BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of BAL PHARMA ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of BAL PHARMA Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹133.7 Cr | 6.6% | 9% | -18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹453,750.0 Cr | 0.6% | 13.6% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,117.0 Cr | 1.5% | 9.1% | 9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,314.0 Cr | 1.5% | 8.2% | 35.7% | Stock Analytics | |
| CIPLA | ₹113,225.0 Cr | -2.1% | 13.7% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,037.0 Cr | -1.4% | 8% | 7.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 6.6% |
9% |
-18.8% |
| SENSEX | -0.3% |
-4.3% |
-8.9% |
You may also like the below Video Courses